Clinical data | |
---|---|
ATC code |
|
Identifiers | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C25H32O4 |
Molar mass | 396.527 g·mol−1 |
3D model (JSmol) | |
| |
|
Anthracimycin is a polyketide antibiotic discovered in 2013. Anthracimycin is derived from marine actinobacteria. In preliminary laboratory research, it has shown activity against Bacillus anthracis,[1] the bacteria that causes anthrax, and against methicillin-resistant Staphylococcus aureus (MRSA).[2]